Premium
Prioritizing Comparative‐Effectiveness Research Topics via Stakeholder Involvement: An Application in COPD
Author(s) -
Pickard A S,
Lee T A,
Solem C T,
Joo M J,
Schumock G T,
Krishnan J A
Publication year - 2011
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1038/clpt.2011.237
Subject(s) - pulmonary disease , copd , clinical pharmacology , stakeholder , process (computing) , medicine , comparative effectiveness research , management science , medical education , process management , business , pharmacology , alternative medicine , political science , computer science , public relations , engineering , pathology , operating system
A major priority for funding agencies and researchers involved in comparative‐effectiveness research (CER) is to ensure that research questions will produce findings that are relevant and feasible to implement. In this article, we describe a process for involving experts and stakeholders in identifying and prioritizing CER studies, as illustrated by our experience in chronic obstructive pulmonary disease (COPD). Clinical Pharmacology & Therapeutics (2011); 90 6, 888–892. doi: 10.1038/clpt.2011.237